SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Paolo Angeli, Pere Ginès, Florence Wong, Mauro Bernardi, Thomas D. Boyer, Alexander Gerbes, Richard Moreau, Rajiv Jalan, Shiv K. Sarin, Salvatore Piano, Kevin Moore, Samuel S. Lee, Francois Durand, Francesco Salerno, Paolo Caraceni, W. Ray Kim, Vicente Arroyo, Guadalupe Garcia-Tsao, Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites, Journal of Hepatology, 2015,

    CrossRef

  2. 2
    Louise Madeleine Risør, Flemming Bendtsen, Søren Møller, Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction, Hepatology International, 2015, 9, 1, 17

    CrossRef

  3. 3
    Shamila T. De Silva, Ruwan P. Perera, Madunil A. Niriella, Arunasalam Pathmeswaran, Hithanadura Janaka de Silva, Frequency, pattern and short-term outcome of chronic renal dysfunction in patients with cirrhosis, European Journal of Gastroenterology & Hepatology, 2014, 26, 11, 1296

    CrossRef

  4. 4
    Felix Darstein, Christina König, Maria Hoppe-Lotichius, Daniel Grimm, Johanna Knapstein, Jens Mittler, Hauke Lang, Peter Robert Galle, Tim Zimmermann, Impact of pancreatic comorbidities in patients with end-stage liver disease on outcome after liver transplantation, European Journal of Internal Medicine, 2014, 25, 3, 281

    CrossRef

  5. 5
    Søren Møller, Aleksander Krag, Flemming Bendtsen, Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes, Liver International, 2014, 34, 8
  6. 6
    Arun J. Sanyal, Manal F. Abdelmalek, Ayako Suzuki, Oscar W. Cummings, Mario Chojkier, No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial, Gastroenterology, 2014, 147, 2, 377

    CrossRef

  7. 7
    Danielle Adebayo, Vincenzo Morabito, Andrew Davenport, Rajiv Jalan, Renal dysfunction in cirrhosis is not just a vasomotor nephropathy, Kidney International, 2014,

    CrossRef

  8. 8
    Salvatore Piano, Marta Tonon, Marta Cavallin, Filippo Morando, Antonietta Romano, Elisabetta Gola, Silvano Fasolato, Paolo Angeli, Reply to: “A cut-off serum creatinine value of 1.5mg/dl for AKI – To be or not to be”, Journal of Hepatology, 2014,

    CrossRef

  9. 9
    J. A. Leithead, P. C. Hayes, J. W. Ferguson, Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction, Alimentary Pharmacology & Therapeutics, 2014, 39, 7
  10. 10
    Jens H. Henriksen, Søren Møller, Ascites, Colloquium Series on Integrated Systems Physiology: From Molecule to Function, 2013, 5, 1, 1

    CrossRef

  11. 11
    Yu-Wei Chen, Chia-Fu Tsai, Tsang-En Wang, Ching-Wei Chang, Chi-Feng Pan, Chih-Jen Wu, Han-Hsiang Chen, Cautious application of the hepatorenal syndrome criteria to critically ill patients with cirrhosis, Liver International, 2013, 33, 6
  12. 12
    Salvatore Piano, Silvia Rosi, Giulio Maresio, Silvano Fasolato, Marta Cavallin, Antonietta Romano, Filippo Morando, Elisabetta Gola, Anna Chiara Frigo, Angelo Gatta, Paolo Angeli, Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites, Journal of Hepatology, 2013, 59, 3, 482

    CrossRef